37
Growth Score in past quarter
pts
Heat Score 37 in past quarter
-37 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
477709
Invitrx Therapeutics is a developer of skin grafts for burn patients.
- Rajen Naidoo: Chief Medical Officer
About the Company
Invitrx was founded by Habib Torfi in 2003 following extensive research and clinical trials utilizing adult stem cell technology to treat patients suffering from burns, diabetic ulcers, ocular surface disorders, and other ophthalmic conditions. Today we’re widely regarded as one of the world’s leading stem cell technology companies.
Over the years
our breakthrough technologies have become instrumental to the creation of numerous life-changing cell therapy products used in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Invitrx has also developed and launched a consumer cosmetics line called Reluma, which features groundbreaking products that recapture the luminosity of youthful skin and hair.